201 related articles for article (PubMed ID: 6330889)
1. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.
Kalyanaraman VS; Cabradilla CD; Getchell JP; Narayanan R; Braff EH; Chermann JC; Barré-Sinoussi F; Montagnier L; Spira TJ; Kaplan J
Science; 1984 Jul; 225(4659):321-3. PubMed ID: 6330889
[TBL] [Abstract][Full Text] [Related]
2. Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome.
Feorino PM; Kalyanaraman VS; Haverkos HW; Cabradilla CD; Warfield DT; Jaffe HW; Harrison AK; Gottlieb MS; Goldfinger D; Chermann JC
Science; 1984 Jul; 225(4657):69-72. PubMed ID: 6328663
[TBL] [Abstract][Full Text] [Related]
3. Survey of the prevalence of AIDS-associated virus (LAV) infection in Japan.
Tsuchie H; Kurimura T; Hinuma Y
J Infect; 1985 May; 10(3):272-6. PubMed ID: 2993425
[TBL] [Abstract][Full Text] [Related]
4. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.
Klatzmann D; Barré-Sinoussi F; Nugeyre MT; Danquet C; Vilmer E; Griscelli C; Brun-Veziret F; Rouzioux C; Gluckman JC; Chermann JC
Science; 1984 Jul; 225(4657):59-63. PubMed ID: 6328660
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
[TBL] [Abstract][Full Text] [Related]
7. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
[TBL] [Abstract][Full Text] [Related]
8. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS.
Barré-Sinoussi F; Mathur-Wagh U; Rey F; Brun-Vezinet F; Yancovitz SR; Rouzioux C; Montagnier L; Mildvan D; Chermann JC
JAMA; 1985 Mar 22-29; 253(12):1737-9. PubMed ID: 2983130
[TBL] [Abstract][Full Text] [Related]
9. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
[TBL] [Abstract][Full Text] [Related]
10. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.
Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC
Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973
[TBL] [Abstract][Full Text] [Related]
11. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.
Tenner-Racz K; Racz P; Bofill M; Schulz-Meyer A; Dietrich M; Kern P; Weber J; Pinching AJ; Veronese-Dimarzo F; Popovic M
Am J Pathol; 1986 Apr; 123(1):9-15. PubMed ID: 3008562
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state.
Laurence J; Brun-Vezinet F; Schutzer SE; Rouzioux C; Klatzmann D; Barré-Sinoussi F; Chermann JC; Montagnier L
N Engl J Med; 1984 Nov; 311(20):1269-73. PubMed ID: 6092953
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
[No Abstract] [Full Text] [Related]
15. Antibody to human T cell leukaemia virus type III in Australian homosexual men with lymphadenopathy.
Frazer IH; Sarngadharan MG; Mackay IR; Gallo RC
Med J Aust; 1984 Sep; 141(5):274-6. PubMed ID: 6088957
[TBL] [Abstract][Full Text] [Related]
16. Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes.
Ellrodt A; Barre-Sinoussi F; Le Bras P; Nugeyre MT; Palazzo L; Rey F; Brun-Vezinet F; Rouzioux C; Segond P; Caquet R
Lancet; 1984 Jun; 1(8391):1383-5. PubMed ID: 6145837
[TBL] [Abstract][Full Text] [Related]
17. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay and enzyme-linked immunoassay of antibodies directed against lymphadenopathy-associated virus (LAV) proteins larger than the core protein (P24).
Neurath AR; Strick N; Lee YS; Nilsen T; Baker L; Sproul P; Rubinstein P; Taylor P; Stevens CE; Gold JW
J Virol Methods; 1985 Oct; 12(1-2):85-92. PubMed ID: 3001122
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.
Hunsmann G; Schneider J; Bayer H; Kurth R; Werner A; Brede HD; Erfle V; Mellert W; Brodt HR; Bergmann L
Klin Wochenschr; 1985 Mar; 63(5):233-5. PubMed ID: 2985862
[TBL] [Abstract][Full Text] [Related]
20. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
